A new report that breast cancer patients treated with low doses of radiation therapy have a heightened risk of heart disease suggests that physicians need to work with patients before, during, and after treatment to minimize that risk, according to an accompanying editorial in the March 14 issue of the New England Journal of Medicine.

 

GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.[1] AdreView is approved for the scintigraphic assessment of myocardial sympathetic innervation (cardiac nerve activity) to assist in the evaluation of patients with New York Heart Association (NYHA) Class II or Class III heart failure and left ventricular ejection fraction (LVEF) ? 35 percent.[2]

 

Network security issues, vital infrastructure upgrades, electronic health record (EHR) implementation and impending federal deadlines will guide priorities this year, according to an independent research study of 100 healthcare provider CIOs and senior IT executives that was commissioned by Level 3 Communications Inc.

Carestream was awarded 43 patents from the U.S. Patent and Trademark Office in 2012 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, capping another strong year for technology development across its businesses. These new patents include: improvements in digital radiography detectors; advanced image processing techniques for digital radiography, mammography exams and specialty applications; and medical imaging advancements for use in intensive care units, orthopedics and mobile X-ray systems.

Merge Healthcare Incorporated featured its iConnect Clinical Enterprise Platform at the HIMSS13 Interoperability Showcase and in Merge's booth at this year's HIMSS conference in New Orleans.

Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.

Carestream announced new measurement tools for chiropractic professionals that make its computer radiography (CR) systems with acquisition/mini-PACS (picture archive and communications system) software an even more attractive and efficient digital image capture and management solution. These systems can be purchased from Carestream or through their authorized Carestream dealers.

Calgary Scientific Inc. has entered into a partnership with Clinisys, to develop electronic medical record (EMR) solutions for healthcare practitioners. The agreement between the two Alberta-based companies will see Calgary Scientific’s Health Canada and U.S. Food and Drug Administration (FDA) diagnostically-cleared medical imaging solution, ResolutionMD, integrated into Clinisys’s cloud-based EMR solution. The integration of powerful visualization, collaboration and mobile tools with the patient record helps clinics to realize many benefits including high quality diagnostics and improved workflows, resulting in a complete circle of care for healthcare practitioners and their patients.

From athletes to individuals suffering from osteoporosis, bone fractures are usually the result of tiny cracks accumulating over time — invisible rivulets of damage that, when coalesced, lead to that painful break.

 

Northwest Community Healthcare (NCH) is unveiling new imaging and lab results functionality for its mobile app, MyNCH, which allows NCH Medical Group patients to view their lab and imaging results with just the tap of a finger on their smartphone.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now